U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07419321) titled 'Social Isolation and Aging in Schizophrenia' on Feb. 10.
Brief Summary: Individuals diagnosed with schizophrenia and related psychotic disorders (SZ) exhibit a markedly elevated risk of premature mortality, with a 10-20-year shorter lifespan relative to the general population. Increased mortality rates in SZ are largely attributable to the early manifestation of medical conditions that normally occur later in life, a process known as 'accelerated aging'. While unhealthy lifestyle behaviors, such as smoking and unhealthy diet, account, in part, for accelerated aging in SZ, the excess of physical comorbidities cannot be solely attribu...